Amgen Ventures
26 portfolio companies · 4 on the map · $300.2M raised · 4 cities
Portfolio map
3 Amgen Ventures portfolio companies on the map.
Portfolio companies
Strand Therapeutics
Boston
Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.
Biotechnology Research$257.2MEst. 2017- TT
Tizona Therapeutics
South San Francisco
Tizona develops next-generation immunotherapies
Biotechnology Research$43MEst. 2015 
BigHat Biosciences
California
BigHat is a biotech company accelerating the design of next-generation antibody therapeutics to improve human health, positioning itself at the forefront of antibody design; it is backed by a notable group of investors.
BiotechnologySeries BEst. 2019
Aitia
Cambridge
Leader in the application of Causal AI and Digital Twins to discover the next generation of breakthrough drugs
Biotechnology ResearchSeries DEst. 2000
More portfolio companies
22 more Amgen Ventures investments we track beyond the map.
Cartography BiosciencesSouth San Francisco · Series B
BioAge LabsRichmond · Series D
AAVantgarde BioMilano · Series B
Genome MedicalSouth San Francisco · Series C
QurAlisCambridge · Series B
ReCode TherapeuticsDallas · Series B
Enlaza TherapeuticsLa Jolla · Series A
Code BiotherapeuticsHatfield · Series A
Hummingbird BioscienceWoodlands · Series C
BeiGeneCambridge · Post-IPO Equity
Kernal BiologicsCambridge · Series A
Gandeeva TherapeuticsVancouver · Series A
AlectorSan Francisco · Series E
DJS AntibodiesHeadington · Seed
Ra PharmaceuticalsCambridge · Series B
Infinity PharmaceuticalsCambridge · Venture
Surface OncologyCambridge · Series A
AllozyneSeattle · Series B
ViaCellBoston · Venture
NoviSciDurham · Seed
TetraLogic PharmaceuticalsMalvern · Series C
Accelerator Corp.Seattle · Series C
Portfolio map
3 Amgen Ventures portfolio companies on the map.